HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinichi Oikawa Selected Research

Simvastatin (Zocor)

3/2010Obesity as a risk factor for coronary events in Japanese patients with hypercholesterolemia on low-dose simvastatin therapy.
8/2008Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a prospective large-scale observational cohort study.
4/2007Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).
11/2005The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study.
9/2005Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).
12/2004Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
4/2003Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.
12/2002Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).
12/2002Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinichi Oikawa Research Topics

Disease

18Type 2 Diabetes Mellitus (MODY)
01/2021 - 04/2002
15Hypercholesterolemia
01/2012 - 01/2002
14Coronary Artery Disease (Coronary Atherosclerosis)
08/2022 - 03/2007
13Atherosclerosis
12/2019 - 01/2002
12Body Weight (Weight, Body)
01/2020 - 04/2002
12Obesity
01/2020 - 04/2002
10Hypertension (High Blood Pressure)
05/2022 - 11/2005
9Diabetes Mellitus
04/2018 - 01/2002
8Insulin Resistance
11/2020 - 08/2004
8Dyslipidemias (Dyslipidemia)
01/2019 - 11/2006
7Neoplasms (Cancer)
04/2018 - 02/2005
7Coronary Disease (Coronary Heart Disease)
05/2012 - 12/2002
6Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 12/2006
6Hyperglycemia
01/2020 - 11/2006
6Stroke (Strokes)
01/2019 - 11/2005
5Xanthomatosis (Xanthoma)
06/2022 - 01/2012
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
08/2022 - 01/2012
4Hyperphagia (Overeating)
01/2020 - 12/2002
4Hemorrhage
06/2019 - 03/2010
4Myocardial Infarction
01/2019 - 03/2007
4Hyperlipidemias (Hyperlipidemia)
01/2017 - 02/2002
4Hypertriglyceridemia
01/2012 - 04/2002
4AIDS-Related Complex (ARC)
09/2006 - 06/2002
3Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2021 - 03/2007
3Glucose Intolerance
11/2020 - 06/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 01/2005
3Diabetes Complications
05/2012 - 08/2010
3Thyrotoxicosis
11/2008 - 12/2003
2Carotid Artery Diseases
06/2022 - 01/2014
2Inborn Genetic Diseases (Disease, Hereditary)
05/2022 - 01/2012
2Hyperaldosteronism (Conn Syndrome)
11/2020 - 01/2017
2Adenoma (Adenomas)
11/2020 - 01/2017
2Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2019 - 01/2016
2Cerebral Hemorrhage
06/2019 - 09/2005
2Homozygous Familial Hypercholesterolemia
02/2019 - 04/2007
2Thrombosis (Thrombus)
04/2018 - 02/2002
2Weight Loss (Weight Reduction)
04/2017 - 01/2013
2Transient Ischemic Attack
01/2016 - 12/2014
2Hyperinsulinism (Hyperinsulinemia)
12/2015 - 05/2010
2Unstable Angina
01/2011 - 03/2007
2Abdominal Obesity
03/2009 - 08/2006
2Hyperlipoproteinemia Type III (Broad Beta Disease)
02/2006 - 02/2002
2Lipoprotein Glomerulopathy
02/2006 - 02/2002
1Gastrointestinal Hemorrhage (Hematochezia)
06/2019

Drug/Important Bio-Agent (IBA)

28LipidsIBA
08/2022 - 01/2002
16Glucose (Dextrose)FDA LinkGeneric
11/2020 - 04/2002
14LDL CholesterolIBA
06/2022 - 01/2002
14HDL CholesterolIBA
05/2022 - 04/2005
13CholesterolIBA
02/2019 - 01/2002
13Triglycerides (Triacylglycerol)IBA
01/2017 - 01/2005
11Insulin (Novolin)FDA Link
01/2021 - 12/2006
10oxidized low density lipoproteinIBA
06/2022 - 02/2005
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2014 - 01/2002
9Simvastatin (Zocor)FDA LinkGeneric
03/2010 - 12/2002
8Blood Glucose (Blood Sugar)IBA
01/2021 - 04/2007
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2019 - 03/2010
6Eicosapentaenoic AcidIBA
01/2012 - 07/2008
5Lipoproteins (Lipoprotein)IBA
08/2022 - 02/2002
5ApolipoproteinsIBA
08/2022 - 02/2002
5LDL Lipoproteins (beta Lipoproteins)IBA
06/2022 - 01/2012
5Messenger RNA (mRNA)IBA
11/2008 - 06/2002
5GhrelinIBA
09/2006 - 09/2002
4LeptinIBA
01/2020 - 12/2002
4HDL LipoproteinsIBA
01/2016 - 01/2008
4phosphatidylcholine hydroperoxideIBA
02/2015 - 04/2002
4Proteins (Proteins, Gene)FDA Link
01/2013 - 06/2002
3N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA
04/2018 - 12/2014
3Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2012 - 04/2002
3Neuropeptide YIBA
11/2008 - 09/2002
3Triiodothyronine (Liothyronine)FDA LinkGeneric
11/2008 - 12/2003
3NeuropeptidesIBA
12/2007 - 05/2005
2Pharmaceutical PreparationsIBA
05/2022 - 08/2009
2AldosteroneIBA
11/2020 - 01/2017
2Ezetimibe (Zetia)FDA Link
01/2019 - 01/2017
2AlbuminsIBA
07/2018 - 11/2013
2Fenofibrate (CiL)FDA LinkGeneric
01/2017 - 04/2005
2AdiponectinIBA
01/2016 - 01/2015
2Phosphatidylcholines (Phosphatidylcholine)IBA
02/2015 - 05/2009
2Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2011 - 12/2009
2Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
11/2010 - 12/2009
2Vitamin EFDA LinkGeneric
09/2009 - 02/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2009 - 08/2008
2Hemoglobins (Hemoglobin)IBA
01/2008 - 01/2008
2Ghrelin ReceptorsIBA
09/2006 - 12/2002
2Apolipoproteins E (ApoE)IBA
02/2006 - 02/2002
2PPAR alphaIBA
04/2005 - 08/2004
2Peptides (Polypeptides)IBA
08/2004 - 09/2002
1Lipoprotein(a)IBA
08/2022
1Heparin (Liquaemin)FDA LinkGeneric
09/2020
1Sitagliptin Phosphate (Januvia)FDA Link
04/2020
1Metformin (Glucophage)FDA LinkGeneric
12/2019
1LDL Receptors (LDL Receptor)IBA
02/2019

Therapy/Procedure

17Therapeutics
06/2019 - 12/2002
7Glycemic Control
01/2021 - 04/2002
3Secondary Prevention
07/2008 - 12/2002
2Liver Transplantation
02/2019 - 04/2007
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2011 - 03/2007
1Injections
01/2021
1Heart Transplantation (Grafting, Heart)
02/2019
1Transplantation
02/2019